Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19)-Reference-Cited by-同舟云学术

Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19)

Published:2020-09-16 Issue:6 Volume:13 Page:1023-1033
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Zubiaur Pablo¹²^ORCID,Koller Dora¹^ORCID,Saiz‐Rodríguez Miriam¹³^ORCID,Navares‐Gómez Marcos¹^ORCID,Abad‐Santos Francisco¹²⁴^ORCID

Affiliation:

1. Clinical Pharmacology Department Hospital Universitario de La PrincesaInstituto Teófilo HernandoUniversidad Autónoma de Madrid (UAM)Instituto de Investigación Sanitaria La Princesa (IP) Madrid Spain

2. UICEC Hospital Universitario de La Princesa Plataforma SCReN (Spanish Clinical Research Network) Instituto de Investigación Sanitaria La Princesa (IP) Madrid Spain

3. Research Unit Fundación Burgos por la Investigación de la Salud Hospital Universitario de Burgos Burgos Spain

4. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12866

Reference127 articles.

1. World Health Organization.Coronavirus disease (COVID‐19) Situation Report – 124..

2. The current understanding and potential therapeutic options to combat COVID-19

3. Pharmacologic treatments for coronavirus disease 2019 (COVID‐19): a review;Sanders J.M.;JAMA

4. World Health Organization.Off‐label use of medicines for COVID‐19..

5. COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions;Back D.;Br. J. Clin. Pharmacol

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Resveratrol Co-Administration on Celecoxib Disposition and Pharmacokinetics in Healthy Volunteers;Drug Research;2023-11

2. Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality;Pulmonary Pharmacology & Therapeutics;2022-12

3. Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?;Pharmaceuticals;2022-06-13

4. Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity;Life Science Alliance;2022-05-30

5. Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?;Journal of Personalized Medicine;2021-11-11